- Home
- PLX vs GGZ Comparison
PLX vs GGZ Comparison
Compare PLX & GGZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PLX
- GGZ
- Stock Information
- Founded
- PLX 1993
- GGZ 2013
- Country
- PLX United States
- GGZ United States
- Employees
- PLX N/A
- GGZ N/A
- Industry
- PLX Biotechnology: Biological Products (No Diagnostic Substances)
- GGZ Investment Managers
- Sector
- PLX Health Care
- GGZ Finance
- Exchange
- PLX Nasdaq
- GGZ Nasdaq
- Market Cap
- PLX 127.4M
- GGZ 109.0M
- IPO Year
- PLX 1998
- GGZ N/A
- Fundamental
- Price
- PLX $1.91
- GGZ $14.51
- Analyst Decision
- PLX Strong Buy
- GGZ
- Analyst Count
- PLX 1
- GGZ 0
- Target Price
- PLX $15.00
- GGZ N/A
- AVG Volume (30 Days)
- PLX 705.4K
- GGZ 12.8K
- Earning Date
- PLX 11-13-2025
- GGZ 01-01-0001
- Dividend Yield
- PLX N/A
- GGZ 5.39%
- EPS Growth
- PLX N/A
- GGZ N/A
- EPS
- PLX 0.08
- GGZ 1.75
- Revenue
- PLX $61,948,000.00
- GGZ N/A
- Revenue This Year
- PLX $14.53
- GGZ N/A
- Revenue Next Year
- PLX $75.77
- GGZ N/A
- P/E Ratio
- PLX $24.60
- GGZ $6.79
- Revenue Growth
- PLX 62.79
- GGZ N/A
- 52 Week Low
- PLX $0.99
- GGZ $9.43
- 52 Week High
- PLX $3.10
- GGZ $12.50
- Technical
- Relative Strength Index (RSI)
- PLX 70.20
- GGZ 66.82
- Support Level
- PLX $1.52
- GGZ $14.27
- Resistance Level
- PLX $1.69
- GGZ $14.65
- Average True Range (ATR)
- PLX 0.08
- GGZ 0.22
- MACD
- PLX 0.03
- GGZ -0.01
- Stochastic Oscillator
- PLX 91.67
- GGZ 65.98
About PLX Protalix BioTherapeutics Inc. (DE)
Protalix BioTherapeutics Inc is a biopharmaceutical company focused on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx protein expression system or ProCellEx. It has developed taliglucerase alfa for the treatment of Gaucher disease. The company's products also treat diseases like Fabry disease and cystic fibrosis. The company's primary sources of revenue include its sales of BioManguinhos alfataliglicerase in Brazil and of drug substances to Pfizer under its Amended Pfizer Agreement. The company's pipeline consists of ELFABRIO, Uricase, and Long Acting DNase I.
About GGZ Gabelli Global Small and Mid Cap Value Trust (The) of Beneficial Interest
The Gabelli Global Small and Mid Cap Value Trust is a diversified closed-ended management investment company whose investment objective is long-term capital growth. It invests in equity securities such as common stock and preferred stock of companies.